← Portfolio Scout

Portfolio company

CND Life Sciences

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechDigital Health

About

This company develops skin biopsy tests to detect alpha-synuclein pathology for clinicians and biopharmaceutical researchers diagnosing neurodegenerative diseases like Parkinson's.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies